Incyte Corporation is a biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for oncology and other serious diseases. Its product portfolio includes treatments for conditions such as myeloproliferative neoplasms and graft-versus-host disease. Incyte operates primarily in the United States and has a commitment to supporting various disease communities through initiatives like the Incyte Ingenuity Awards.
